News

AB Akola Group Achieves Outstanding Financial Growth in 9 Months

AB Akola Group Achieves Outstanding Financial Growth in 9 Months

AB Akola Group's Remarkable Financial Performance

AB Akola Group, encompassing a wide array of agricultural and food production ventures, has reported exceptional financial outcomes for the first nine months of the financial year. The company achieved consolidated revenue exceeding EUR 1,165 million, which showcases a solid 3.59% increase compared to last year's figures.

Adding to this success, the Group's consolidated EBITDA surpassed EUR 71 million, amplifying by 34.83% year-over-year, while net profit more than doubled at EUR 31.8 million. This substantial growth indicates the company's resilience and effective positioning within the market, as they sold 2,417 thousand tons of diverse products.

Insights into Quarterly Growth

Looking at the third quarter specifically, AB Akola Group reported a revenue of EUR 404.2 million, reflecting a notable 3.96% enhancement from previous figures. The gross profit for the quarter surged from EUR 32.1 million to EUR 47.9 million, alongside an operating profit climb from EUR 6.3 million to EUR 18.3 million. Thus, net profit reached EUR 12.7 million, a striking turnaround from a loss in the same period the previous year.

Success Across Business Segments

Mažvydas Šileika, Chief Financial Officer of AB Akola Group, expressed satisfaction with these results, stating that although the quantity of products sold increased modestly, profitability saw significant enhancements. Three out of four business segments recorded profitable operations, with the poultry segment notably standing out as a key driver of success during this timeframe.

Partnership with Farmers

The "Partnership with Farmers" segment emerged as the cornerstone of the Group's operations, generating robust revenue exceeding EUR 851.7 million. This segment contributed a significant 68.1% to the Group's total revenue. Gross profit reached EUR 65.4 million, with operating profit rising to EUR 20.8 million compared to EUR 19.2 million from the year before.

Notably, while the volume of grain purchases saw a slight reduction, the overall trading performance improved. Wheat sales remained consistent, making up the majority of the portfolio, while the sale of rapeseed saw a minor decrease. The gross profit from grain and oilseed trading surged by 33%, reflecting the healthy market performance. Fertilizer sales also rose, indicating an increase in agricultural activity.

Food Production Segment Growth

The performance of the "Food Production" segment was equally impressive, with revenues exhibiting a significant year-on-year increase of 10.7%. Operating profits reached EUR 24.985 million, while gross profit swelled notably to EUR 57.5 million. The poultry sector was especially impactful, witnessing a 92.9% escalation in gross profit to EUR 44.46 million. The favorable conditions, including lower feed prices and heightened market demand, have amplified this segment’s profitability.

Future Outlook and Investments

Despite the positive financial outlook, challenges remain evident, particularly in the agricultural machinery market, which has experienced stagnation. However, with the arrival of spring and expectations of a fruitful harvest, there appears to be a promising uptick in the demand for agricultural machinery.

Moreover, the Group is excited about the potential of new investments in agricultural technologies and processes aimed at enhancing productivity across all segments.

About AB Akola Group

AB Akola Group stands as the largest agricultural and food production conglomerate in the Baltics, employing over 5,000 individuals. The Group is engaged along the entire food production chain, encompassing activities from cultivation to marketing of agricultural products, while providing vital services to farmers.

For further inquiries or details about AB Akola Group's activities and financials, interested parties can reach out to Mažvydas Šileika, Chief Financial Officer, via mobile at +370 619 19 403 or through email at m.sileika@akolagroup.lt.

Frequently Asked Questions

What was the net profit for AB Akola Group?

AB Akola Group's net profit for the first nine months reached EUR 31.8 million, showing more than a 100% increase compared to last year.

How much revenue did AB Akola Group generate?

The consolidated revenue for the Group exceeded EUR 1,165 million for the nine-month period of FY 2024/2025.

Which segment of AB Akola Group showed the most growth?

The "Food Production" segment displayed outstanding growth, particularly in poultry, which saw significant increases in both revenue and profitability.

How does AB Akola Group support farmers?

The Group engages in various activities aimed at supporting farmers, including providing seeds, fertilizers, and other essential agricultural services while maintaining partnerships that enhance productivity.

Who should I contact for more information about AB Akola Group?

For more information, you can contact Mažvydas Šileika, the Chief Financial Officer, via mobile at +370 619 19 403 or email at m.sileika@akolagroup.lt.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 141

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 336

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 206

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 265

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Milestone Scientific Gains Approval for Federal Supply Schedule

Updated Category News Views 102

Milestone Scientific's Key Approval for CompuFlo® System Milestone Scientific Inc. (MLSS), a prominent name in the medical technology industry, has recently achieved a significant milestone by securing approval for the Federal Supply Schedule (FSS) concerning its CompuFlo® Epidural System. This news marks a substantial step for the company, which specializes in...

Continue Reading
Small Business Confidence Surges Ahead of 2026, Report Reveals

Updated Category News Views 321

Small Businesses Show Robust Resilience for 2026 As we approach a new year, the outlook for small businesses is remarkably positive, despite facing significant challenges from tariffs and inflation. The Comerica Small Business Pulse Index™ has released findings showcasing that small business owners nationwide are mostly hopeful about 2026, with many predicting growth...

Continue Reading
Investors Speak Out: Trade Desk, Inc. Class Action Unfolding

Updated Category News Views 98

Understanding the Trade Desk Class Action Lawsuit Trade Desk, Inc., renowned for its innovative advertising technology, is currently facing a class action lawsuit that has captured the attention of many investors and legal experts alike. The lawsuit, recently filed, comes on the heels of troubling financial results indicating severe challenges in the company's recent...

Continue Reading
Kalmar Corporation Prepares for 2024 Financial Statement Release

Updated Category News Views 115

Kalmar Corporation's Upcoming Financial Statements Review Kalmar Corporation is gearing up to unveil its much-anticipated financial statements review for the year 2024. Scheduled for release at approximately 9:00 a.m. EET, the report promises to offer a comprehensive look into the company’s financial health and operational successes over the past year. Details About the...

Continue Reading
Analyzing the Short Interest Trends for AutoZone Inc

Updated Category News Views 96

Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...

Continue Reading